Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12521 | 837 | 39.6 | 86% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P53 AUTOANTIBODIES | Author keyword | 42 | 94% | 2% | 15 |
2 | ANTI P53 ANTIBODY | Author keyword | 34 | 93% | 2% | 13 |
3 | SERUM P53 ANTIBODY | Author keyword | 33 | 100% | 2% | 13 |
4 | P53 ANTIBODIES | Author keyword | 27 | 71% | 3% | 22 |
5 | ANTI P53 ANTIBODIES | Author keyword | 25 | 77% | 2% | 17 |
6 | SERUM P53 ANTIBODIES | Author keyword | 17 | 100% | 1% | 8 |
7 | SERPA | Author keyword | 11 | 69% | 1% | 9 |
8 | ANTI P53 AUTOANTIBODIES | Author keyword | 9 | 83% | 1% | 5 |
9 | ANTI P53 | Author keyword | 8 | 75% | 1% | 6 |
10 | ONCIMMUNE LTD | Address | 8 | 75% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P53 AUTOANTIBODIES | 42 | 94% | 2% | 15 | Search P53+AUTOANTIBODIES | Search P53+AUTOANTIBODIES |
2 | ANTI P53 ANTIBODY | 34 | 93% | 2% | 13 | Search ANTI+P53+ANTIBODY | Search ANTI+P53+ANTIBODY |
3 | SERUM P53 ANTIBODY | 33 | 100% | 2% | 13 | Search SERUM+P53+ANTIBODY | Search SERUM+P53+ANTIBODY |
4 | P53 ANTIBODIES | 27 | 71% | 3% | 22 | Search P53+ANTIBODIES | Search P53+ANTIBODIES |
5 | ANTI P53 ANTIBODIES | 25 | 77% | 2% | 17 | Search ANTI+P53+ANTIBODIES | Search ANTI+P53+ANTIBODIES |
6 | SERUM P53 ANTIBODIES | 17 | 100% | 1% | 8 | Search SERUM+P53+ANTIBODIES | Search SERUM+P53+ANTIBODIES |
7 | SERPA | 11 | 69% | 1% | 9 | Search SERPA | Search SERPA |
8 | ANTI P53 AUTOANTIBODIES | 9 | 83% | 1% | 5 | Search ANTI+P53+AUTOANTIBODIES | Search ANTI+P53+AUTOANTIBODIES |
9 | ANTI P53 | 8 | 75% | 1% | 6 | Search ANTI+P53 | Search ANTI+P53 |
10 | P53 ANTIBODY | 5 | 60% | 1% | 6 | Search P53+ANTIBODY | Search P53+ANTIBODY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTI P53 ANTIBODIES | 120 | 83% | 8% | 68 |
2 | P53 ANTIBODIES | 66 | 69% | 7% | 56 |
3 | CELLULAR PROTEIN P53 | 49 | 66% | 5% | 45 |
4 | PROTEOMICS BASED IDENTIFICATION | 34 | 58% | 5% | 39 |
5 | P53 AUTOANTIBODIES | 32 | 78% | 3% | 21 |
6 | ANTI P53 ANTIBODY RESPONSE | 18 | 83% | 1% | 10 |
7 | SERUM P53 ANTIBODIES | 12 | 50% | 2% | 17 |
8 | P53 ANTIBODY | 12 | 86% | 1% | 6 |
9 | SERUM P53 ANTIBODY | 12 | 86% | 1% | 6 |
10 | TIME RESOLVED IMMUNOFLUOROMETRY | 12 | 86% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Systematic review: Serum autoantibodies in the early detection of gastric cancer | 2015 | 3 | 50 | 62% |
p53 antibodies in the sera of patients with various types of cancer: A review | 2000 | 331 | 131 | 66% |
Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer | 2014 | 4 | 74 | 66% |
Serum autoantibodies in the early detection of esophageal cancer: a systematic review | 2015 | 1 | 57 | 70% |
Serum autoantibodies as biomarkers for early cancer detection | 2009 | 103 | 228 | 49% |
Serologic Autoantibodies as Diagnostic Cancer Biomarkers-A Review | 2013 | 12 | 86 | 57% |
A systematic review of humoral immune responses against tumor antigens | 2009 | 85 | 115 | 50% |
Use of Autoantibodies to Detect the Onset of Breast Cancer | 2014 | 2 | 30 | 73% |
Autoantibody signatures: progress and perspectives for early cancer detection | 2011 | 30 | 55 | 60% |
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer | 2008 | 65 | 56 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCIMMUNE LTD | 8 | 75% | 0.7% | 6 |
2 | EXCELLENCE AUTOIMMUN CANC | 4 | 67% | 0.5% | 4 |
3 | ONCOPROTE CLIN | 3 | 60% | 0.4% | 3 |
4 | HENAN TUMOR EPIDEMIOL | 3 | 35% | 0.7% | 6 |
5 | WM KECK AUTOIMMUNE DIS | 2 | 14% | 1.8% | 15 |
6 | BIOL THER Y UNIT | 2 | 67% | 0.2% | 2 |
7 | BRIGHAM WOMENS HOSP UROL | 2 | 67% | 0.2% | 2 |
8 | ENVIRONM RADIAT BIOL | 2 | 67% | 0.2% | 2 |
9 | TUMOR VACCINE GRP | 2 | 15% | 1.4% | 12 |
10 | TRANSLAT MED WOMENS HLTH | 2 | 18% | 1.1% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000154363 | GEL FIBERGLASS//TERATOL EXPT ONCOL//RAT COLON CANCER |
2 | 0.0000136440 | BVES//STAHLMAN CARDIOVASC S//LEK1 |
3 | 0.0000109887 | IMP3//IGF2BP3//L523S |
4 | 0.0000089889 | CANCER TESTIS ANTIGEN//CANCER TESTIS ANTIGENS//NY ESO 1 |
5 | 0.0000085401 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
6 | 0.0000079103 | CALUMENIN//BIOCHEM FUNCT PROTE//RETICULOCALBIN |
7 | 0.0000073410 | P53 GENE//P53 MUTANTS//MUTANT P53 |
8 | 0.0000072459 | SW MED SIMMONS CANC//COPY NUMBER LOSS//K RAS GENOTYPES |
9 | 0.0000071098 | CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS |
10 | 0.0000070018 | ANTIBODY MICROARRAYS//PROTEIN MICROARRAY//PROTEIN MICROARRAYS |